Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis

Nutr Metab Cardiovasc Dis. 2020 Jun 9;30(6):889-895. doi: 10.1016/j.numecd.2020.02.017. Epub 2020 Mar 7.

Abstract

Aims: Kisspeptin-10 (KP-10), a potent vasoconstrictor and inhibitor of angiogenesis, and its receptor, GPR54, have currently received much attention with respect to atherosclerosis, since both KP-10 and GPR54 are expressed at high levels in atheromatous plaques and restenotic lesions after wire-injury. The present review introduces the emerging roles of the KP-10/GPR54 system in atherosclerosis.

Data synthesis: KP-10 suppresses migration and proliferation of human umbilical vein endothelial cells (HUVECs), and induces senescence in HUVECs. KP-10 increases adhesion of human monocytes to HUVECs. KP-10 also stimulates expression of interleukin-6, tumor necrosis factor-α, monocyte chemotactic protein-1, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin genes in HUVECs. KP-10 enhances oxidized low-density lipoprotein-induced foam cell formation associated with upregulation of CD36 and acyl-coenzyme A: cholesterol acyltransferase-1 in human monocyte-derived macrophages. In human aortic smooth muscle cells, KP-10 suppresses angiotensin II-induced migration and proliferation, however, it enhances apoptosis and activities of matrix metalloproteinase (MMP)-2 and MMP-9 by upregulation of extracellular signal-regulated kinase 1/2, p38, Bax, and caspase-3. Four-week-infusion of KP-10 into Apoe-/- mice accelerates development of aortic atherosclerotic lesions with increased monocyte/macrophage infiltration and vascular inflammation, also, it decreases intraplaque vascular smooth muscle cell content. Proatherosclerotic effects of endogenous and exogenous KP-10 were completely attenuated upon infusion of P234, a GPR54 antagonist, in Apoe-/- mice.

Conclusion: These findings suggest that KP-10 may contribute to acceleration of progression and to the instability of atheromatous plaques, leading to rupture of plaques. This GPR54 antagonist may be useful for the prevention and treatment of atherosclerosis. Thus, the KP-10/GPR54 system may serve as a novel therapeutic target for atherosclerotic diseases.

Keywords: Atherosclerosis; Endothelial cell; GPR54; Kisspeptin; Macrophage; Vascular smooth muscle cell.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Atherosclerosis / drug therapy
  • Atherosclerosis / metabolism*
  • Atherosclerosis / pathology
  • Blood Vessels / drug effects
  • Blood Vessels / metabolism*
  • Blood Vessels / pathology
  • Cardiovascular Agents / therapeutic use
  • Cell Movement
  • Cell Proliferation
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Humans
  • Kisspeptins / metabolism*
  • Macrophages / metabolism
  • Macrophages / pathology
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Plaque, Atherosclerotic*
  • Platelet Aggregation
  • Receptors, Kisspeptin-1 / antagonists & inhibitors
  • Receptors, Kisspeptin-1 / metabolism*
  • Signal Transduction

Substances

  • Cardiovascular Agents
  • KISS1R protein, human
  • Kisspeptins
  • Receptors, Kisspeptin-1